Developer docs
API playgroundTry for free, no card

Search company profiles

Hester Biosciences Limited

Full company profile

uuid004kiij

Namestring
Hester Biosciences Limited
Legal namestring
Hester Biosciences Limited
Websiteurl
hester.in
Company typeenum
Public
Founded yearint
1987
Descriptiontext

Hester Biosciences Limited is a publicly listed Indian animal healthcare company headquartered in Mehsana, Gujarat, founded in 1987 by Rajiv Gandhi. The company manufactures and sells live attenuated animal vaccines (including PPR, Goat Pox, Newcastle Disease and Infectious Bursal Disease vaccines), health supplements (probiotics, toxin binders, vitamin-mineral supplements, multi-mineral and calcium supplements, udder disinfectants, uterine tonics, metabolic stabilizers), and medicated pet care products. It self-describes as the second-largest poultry vaccine manufacturer in India and as Asia's largest one-stop animal biological manufacturing facility, claiming 75% of global PPR vaccine demand and over 70% of India's goat pox vaccine segment.

The company operates three manufacturing plants in India (6.25 billion doses/year), Nepal (1.24 billion doses/year), and Tanzania (1.50 billion doses/year) through wholly-owned subsidiaries. It reaches customers via a B2B distribution network of more than 900 distributors in India, supplemented by company depots in Bangalore and Hyderabad, C&F agents, consignee agents across multiple states, and international channel partners such as Novapharma in Egypt. Strategic partnerships with Bill & Melinda Gates Foundation and GALVmed anchor its presence in donor-funded smallholder poultry vaccination programs. The company also sells premium therapeutic pet nutrition under the Fortify brand for dogs and cats, covering renal, cardiac, hepatic, gastrointestinal, mobility, struvite, obesity, and hypoallergenic conditions.

Hester monetizes through one-time unit sales of biologicals and therapeutics plus limited professional services through diagnostic labs. Pricing is not publicly disclosed and no per-dose or list pricing information is available. Customer segments include commercial poultry operations, livestock farmers (including dairy), smallholder farmers in underserved regions, veterinary professionals, and pet owners. The company is 38 years old as of the data period, employs 481 staff, and reports a presence in 35+ countries.

Short descriptiontext

Hester Biosciences Limited is an Indian-listed animal healthcare company that manufactures live attenuated vaccines and health supplements for poultry and livestock, with operations in India, Nepal and Tanzania. It serves commercial poultry and dairy farmers, smallholder farmers, veterinarians, and pet owners through 900+ distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersMehsana, India
HQ citystring
Mehsana
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal healthcare, poultry vaccines, veterinary biologicals, livestock health products, pet nutrition
Industry2 codes
PRIMARYHLAMAKAI
Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO)
SECONDARYHLAMAHAD
Livestock & Poultry Nutrition (Feed & Premixes)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Nutrition & Therapeutic Diets
NAICS code3 codes
  • Dog and Cat Food Manufacturing311111
  • Animal Food Manufacturing31111
  • Other Animal Food Manufacturing311119
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Food And Kindred Products2000
Product category
Animal Healthcare
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Poultry Vaccines
TypeOne Time License
Description

Manufacturing and sale of poultry vaccines including monovalent and bivalent vaccines for Newcastle Disease (ND) and Infectious Bursal Disease (IBD). Second largest poultry vaccine manufacturer in India.

hester.in
2Animal Health Products
TypeOne Time License
Description

Health supplements, therapeutic solutions, PPR vaccines, Goat Pox vaccines, multi-mineral supplements, udder disinfectants, and metabolic stabilizers for livestock.

hester.in
3Pet Care Products
TypeOne Time License
Description

Fortify pet diet food products including therapeutic pet foods for various conditions (cardiac, renal, hepatic, mobility, gastrointestinal) and medicated shampoos/sprays.

hester.in
4Diagnostic Labs
TypeProfessional Services
Description

End-to-end diagnostic solutions and services for animal healthcare.

hester.in
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Fortify
Description

Premium nutrition pet diet food brand offering therapeutic and specialized food products for dogs and cats, including products for gastrointestinal, renal/urinary, struvite, hepatic, cardiac, mobility, and fiber response conditions.

hester.in
Core offering1 text field

Hester Biosciences Limited manufactures and sells veterinary biologicals and animal healthcare products. Its portfolio includes live attenuated poultry and livestock vaccines (PPR, Goat Pox, Newcastle Disease and Infectious Bursal Disease), health supplements and therapeutics for poultry and dairy animals, and the Fortify line of therapeutic pet diet food for dogs and cats. Production is supported by three manufacturing plants in India, Nepal and Tanzania, with distribution through company depots, C&F agents, consignee agents and 900+ distributors across India and 35+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 75% of global PPR vaccine demand supplied
+4 more records
Product overview1 text field

Hester Biosciences Limited operates as a diversified animal healthcare company offering a unified portfolio of vaccines, health products, and pet care solutions. The core offerings consist of vaccines (poultry and animal vaccines including PPR, Goat Pox, ND, IBD) and health products (poultry supplements, multi-mineral supplements, anti-fungal products). The company has expanded into pet care with its Fortify brand of therapeutic pet diets for dogs and cats, addressing conditions such as gastrointestinal issues, renal/urinary problems, cardiac conditions, hepatic disorders, mobility issues, obesity, and struvite stones. The company operates manufacturing plants in India, Nepal, and Tanzania, with strategic presence across 35+ countries and a network of 900+ distributors.

Product and service14 records
1Vaccines
CategoryVeterinary Vaccines
Description

Live attenuated vaccines for poultry and livestock, including Peste des Petits Ruminants (PPR) vaccines, Goat Pox vaccines, Newcastle Disease (ND) monovalent and bivalent vaccines, and Infectious Bursal Disease (IBD) vaccines, sold to poultry operators, livestock farmers and government immunization programs.

2Health Products
CategoryAnimal Health Supplements
Description

Animal health supplements and therapeutics including probiotics, toxin binders, vitamin-mineral supplements, liver tonics for poultry; multi-mineral and calcium supplements, udder disinfectants, uterine tonics, and metabolic stabilizers for dairy herds; and medicated shampoos and anti-fungal sprays with Chlorhexidine, Ketoconazole, Aloe Vera and Tea Tree Oil for pet skin conditions.

3Fortify Diet Food (Pet Care Brand)
CategoryPet Nutrition
Description

Premium pet diet food brand for dogs and cats with gluten-free formulations, featuring Fortify Function Herbal Complex and Fortify Immunity Herbal Complex, marketed across therapeutic variants for gastrointestinal, renal/urinary, struvite, hepatic, cardiac, mobility, and fiber response/obesity conditions.

4Fortify Diet Cat Gastrointestinal/Hypoallergenic
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing gastrointestinal issues in cats.

5Fortify Diet Cat Renal/Urinary
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing impaired renal function in cats.

6Fortify Diet Cat Struvite
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing struvite stones in cats.

7Fortify Diet Dog Cardio
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing cardiac conditions in dogs.

8Fortify Diet Dog Fiber Response
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing obesity issues in dogs.

9Fortify Diet Dog Gastrointestinal/Hypoallergenic
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing gastrointestinal issues in dogs.

10Fortify Diet Dog Hepatic
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing impaired hepatic function in dogs.

11Fortify Diet Dog Mobility
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing mobility issues in dogs.

12Fortify Diet Dog Renal/Urinary
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing impaired renal function in dogs.

13Fortify Diet Dog Struvite
CategoryPet Nutrition
Description

Comprehensive therapeutic pet diet addressing struvite stones in dogs.

14Diagnostic Labs
CategoryVeterinary Diagnostics
Description

End-to-end diagnostic solutions and services for animal healthcare, offered to veterinary clinics, livestock and poultry operators as part of Hester's comprehensive service portfolio.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1GALVmed
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hester completed one of the world's largest backyard poultry immunization programs in collaboration with GALVmed. The initiative helped reach smallholder farmers in India's most underserved regions with access to critical poultry vaccines. Delivered 20 million+ vaccine doses, reached 35 districts across Jharkhand, Odisha, and Chhattisgarh, engaged 40k+ poultry keepers, and achieved 0% reduction in mortality among poultry and goats.

annualreport2025.hester.in
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Golchha Organisation for animal healthcare initiatives.

3Novapharma
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Latest foray into the Egyptian market with Novapharma for distribution of animal healthcare products.

hester.in
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hester Biosciences Limited

Animal Healthcarehester.in

Hester Biosciences Limited is an Indian-listed animal healthcare company that manufactures live attenuated vaccines and health supplements for poultry and livestock, with operations in India, Nepal and Tanzania. It serves commercial poultry and dairy farmers, smallholder farmers, veterinarians, and pet owners through 900+ distributors.

What Hester Biosciences Limited does

Hester Biosciences Limited is a publicly listed Indian animal healthcare company headquartered in Mehsana, Gujarat, founded in 1987 by Rajiv Gandhi. The company manufactures and sells live attenuated animal vaccines (including PPR, Goat Pox, Newcastle Disease and Infectious Bursal Disease vaccines), health supplements (probiotics, toxin binders, vitamin-mineral supplements, multi-mineral and calcium supplements, udder disinfectants, uterine tonics, metabolic stabilizers), and medicated pet care products. It self-describes as the second-largest poultry vaccine manufacturer in India and as Asia's largest one-stop animal biological manufacturing facility, claiming 75% of global PPR vaccine demand and over 70% of India's goat pox vaccine segment.

The company operates three manufacturing plants in India (6.25 billion doses/year), Nepal (1.24 billion doses/year), and Tanzania (1.50 billion doses/year) through wholly-owned subsidiaries. It reaches customers via a B2B distribution network of more than 900 distributors in India, supplemented by company depots in Bangalore and Hyderabad, C&F agents, consignee agents across multiple states, and international channel partners such as Novapharma in Egypt. Strategic partnerships with Bill & Melinda Gates Foundation and GALVmed anchor its presence in donor-funded smallholder poultry vaccination programs. The company also sells premium therapeutic pet nutrition under the Fortify brand for dogs and cats, covering renal, cardiac, hepatic, gastrointestinal, mobility, struvite, obesity, and hypoallergenic conditions.

Hester monetizes through one-time unit sales of biologicals and therapeutics plus limited professional services through diagnostic labs. Pricing is not publicly disclosed and no per-dose or list pricing information is available. Customer segments include commercial poultry operations, livestock farmers (including dairy), smallholder farmers in underserved regions, veterinary professionals, and pet owners. The company is 38 years old as of the data period, employs 481 staff, and reports a presence in 35+ countries.

Hester Biosciences Limited firmographics

Firmographics
Name
Hester Biosciences Limited
Legal name
Hester Biosciences Limited
Website
https://hester.in
Company type
Public
Founded year
1987
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Hester Biosciences Limited is an Indian-listed animal healthcare company that manufactures live attenuated vaccines and health supplements for poultry and livestock, with operations in India, Nepal and Tanzania. It serves commercial poultry and dairy farmers, smallholder farmers, veterinarians, and pet owners through 900+ distributors.
Ownership category
akta.pro rank

Hester Biosciences Limited industry classification

Industry
Product category
Animal Healthcare
NAICS
Dog and Cat Food Manufacturing (311111), Animal Food Manufacturing (31111), Other Animal Food Manufacturing (311119)
SIC
Biological Products, (No Disgnostic Substances) (2836), Food And Kindred Products (2000)
akta.pro industry
PRIMARYHLAMAKAI
Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO)
SECONDARYHLAMAHAD
Livestock & Poultry Nutrition (Feed & Premixes)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Nutrition & Therapeutic Diets

Keywords

  • Animal healthcare
  • Poultry vaccines
  • Veterinary biologicals
  • Livestock health products
  • Pet nutrition

Where Hester Biosciences Limited is headquartered

Location

Headquarters

HQ city
Mehsana
HQ country
India
HQ region
Asia

Offices7 records

Markets served

Hester Biosciences Limited business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Revenue model

  1. Poultry Vaccines: Manufacturing and sale of poultry vaccines including monovalent and bivalent vaccines for Newcastle Disease (ND) and Infectious Bursal Disease (IBD). Second largest poultry vaccine manufacturer in India.
  2. Animal Health Products: Health supplements, therapeutic solutions, PPR vaccines, Goat Pox vaccines, multi-mineral supplements, udder disinfectants, and metabolic stabilizers for livestock.
  3. Pet Care Products: Fortify pet diet food products including therapeutic pet foods for various conditions (cardiac, renal, hepatic, mobility, gastrointestinal) and medicated shampoos/sprays.
  4. Diagnostic Labs: End-to-end diagnostic solutions and services for animal healthcare.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Hester Biosciences Limited product offering

Product offering

Core offering

Hester Biosciences Limited manufactures and sells veterinary biologicals and animal healthcare products. Its portfolio includes live attenuated poultry and livestock vaccines (PPR, Goat Pox, Newcastle Disease and Infectious Bursal Disease), health supplements and therapeutics for poultry and dairy animals, and the Fortify line of therapeutic pet diet food for dogs and cats. Production is supported by three manufacturing plants in India, Nepal and Tanzania, with distribution through company depots, C&F agents, consignee agents and 900+ distributors across India and 35+ countries.

Product overview

Hester Biosciences Limited operates as a diversified animal healthcare company offering a unified portfolio of vaccines, health products, and pet care solutions. The core offerings consist of vaccines (poultry and animal vaccines including PPR, Goat Pox, ND, IBD) and health products (poultry supplements, multi-mineral supplements, anti-fungal products). The company has expanded into pet care with its Fortify brand of therapeutic pet diets for dogs and cats, addressing conditions such as gastrointestinal issues, renal/urinary problems, cardiac conditions, hepatic disorders, mobility issues, obesity, and struvite stones. The company operates manufacturing plants in India, Nepal, and Tanzania, with strategic presence across 35+ countries and a network of 900+ distributors.

Differentiator

Problem solved

Functional benefit

Brands

  • Fortify: Premium nutrition pet diet food brand offering therapeutic and specialized food products for dogs and cats, including products for gastrointestinal, renal/urinary, struvite, hepatic, cardiac, mobility, and fiber response conditions.

Products and services

  • Vaccines Live attenuated vaccines for poultry and livestock, including Peste des Petits Ruminants (PPR) vaccines, Goat Pox vaccines, Newcastle Disease (ND) monovalent and bivalent vaccines, and Infectious Bursal Disease (IBD) vaccines, sold to poultry operators, livestock farmers and government immunization programs.
  • Health Products Animal health supplements and therapeutics including probiotics, toxin binders, vitamin-mineral supplements, liver tonics for poultry; multi-mineral and calcium supplements, udder disinfectants, uterine tonics, and metabolic stabilizers for dairy herds; and medicated shampoos and anti-fungal sprays with Chlorhexidine, Ketoconazole, Aloe Vera and Tea Tree Oil for pet skin conditions.
  • Fortify Diet Food (Pet Care Brand) Premium pet diet food brand for dogs and cats with gluten-free formulations, featuring Fortify Function Herbal Complex and Fortify Immunity Herbal Complex, marketed across therapeutic variants for gastrointestinal, renal/urinary, struvite, hepatic, cardiac, mobility, and fiber response/obesity conditions.
  • Fortify Diet Cat Gastrointestinal/Hypoallergenic Comprehensive therapeutic pet diet addressing gastrointestinal issues in cats.
  • Fortify Diet Cat Renal/Urinary Comprehensive therapeutic pet diet addressing impaired renal function in cats.
  • Fortify Diet Cat Struvite Comprehensive therapeutic pet diet addressing struvite stones in cats.
  • Fortify Diet Dog Cardio Comprehensive therapeutic pet diet addressing cardiac conditions in dogs.
  • Fortify Diet Dog Fiber Response Comprehensive therapeutic pet diet addressing obesity issues in dogs.
  • Fortify Diet Dog Gastrointestinal/Hypoallergenic Comprehensive therapeutic pet diet addressing gastrointestinal issues in dogs.
  • Fortify Diet Dog Hepatic Comprehensive therapeutic pet diet addressing impaired hepatic function in dogs.
  • Fortify Diet Dog Mobility Comprehensive therapeutic pet diet addressing mobility issues in dogs.
  • Fortify Diet Dog Renal/Urinary Comprehensive therapeutic pet diet addressing impaired renal function in dogs.
  • Fortify Diet Dog Struvite Comprehensive therapeutic pet diet addressing struvite stones in dogs.
  • Diagnostic Labs End-to-end diagnostic solutions and services for animal healthcare, offered to veterinary clinics, livestock and poultry operators as part of Hester's comprehensive service portfolio.

Quantifiable outcome

  • 75% of global PPR vaccine demand supplied
  • +4 more outcomes

Companies that use Hester Biosciences Limited

Customer profile

Segments5 records

Hester Biosciences Limited technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Hester Biosciences Limited partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • GALVmedcoreStrategic or Co-development PartnerHester completed one of the world's largest backyard poultry immunization programs in collaboration with GALVmed. The initiative helped reach smallholder farmers in India's most underserved regions with access to critical poultry vaccines. Delivered 20 million+ vaccine doses, reached 35 districts across Jharkhand, Odisha, and Chhattisgarh, engaged 40k+ poultry keepers, and achieved 0% reduction in mortality among poultry and goats.
  • Golchha OrganisationminorStrategic or Co-development PartnerPartnership with Golchha Organisation for animal healthcare initiatives.
  • NovapharmaminorChannel Partner/ Reseller/ DistributorLatest foray into the Egyptian market with Novapharma for distribution of animal healthcare products.

Scale indicators11 records

Recent moves9 records

Expansion highlights6 records

Hester Biosciences Limited competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Hester Biosciences Limited social profiles

Digital presence

Hester Biosciences Limited financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hester Biosciences Limited leadership team

Management profile

Number of profiles

Hester Biosciences Limited subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Hester Biosciences Limited funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hester Biosciences Limited M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hester Biosciences Limited

What does Hester Biosciences Limited do?

Hester Biosciences Limited manufactures and sells veterinary biologicals and animal healthcare products. Its portfolio includes live attenuated poultry and livestock vaccines (PPR, Goat Pox, Newcastle Disease and Infectious Bursal Disease), health supplements and therapeutics for poultry and dairy animals, and the Fortify line of therapeutic pet diet food for dogs and cats. Production is supported by three manufacturing plants in India, Nepal and Tanzania, with distribution through company depots, C&F agents, consignee agents and 900+ distributors across India and 35+ countries.

Is Hester Biosciences Limited a public or private company?

Hester Biosciences Limited is a public company. It is classified as public and is currently operating.

When was Hester Biosciences Limited founded?

Hester Biosciences Limited was founded in 1987. It employs 501 to 1,000 people.

Where is Hester Biosciences Limited based?

Hester Biosciences Limited is headquartered in Mehsana, India, in the Asia region.

How does Hester Biosciences Limited make money?

Four revenue lines are on record. Poultry Vaccines are the primary driver. The others are animal Health Products, pet Care Products and diagnostic Labs.

Does Hester Biosciences Limited have an API?

No public API is recorded for Hester Biosciences Limited.

What industry is Hester Biosciences Limited in?

Hester Biosciences Limited's product category is Animal Healthcare. Its primary akta.pro industry code is HLAMAKAI, Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO), with a secondary code of HLAMAHAD, Livestock & Poultry Nutrition (Feed & Premixes). Its NAICS code is 311111 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXHester Biosciences closes trading window from October 1 for Q2FY27Hester Biosciences closed its trading window from October 1, 2026, ahead of announcing Q2FY27 and H1FY27 results. The closure complies with SEBI insider trading regulations and remains open for 48 hours after results are public.YahooHester Biosciences Ltd (BOM:524669) (Q1 2027) Earnings Call Highlights: Poultry Surge Drives ...Hester Biosciences Ltd reported Q1 2027 earnings with standalone revenue growing 14% year over year and profit after tax surging 88% year over year, driven by a 48% growth in its Poultry Healthcare Division and improved gross margins from 69% to 78%. Consolidated revenue declined 8% year over year due to lower revenues from Nepal and Africa operations, while the Gates Foundation amended Hester Africa's soft loan by reducing it from USD 12 million to USD 5 million and waiving accrued interest. Management flagged ongoing volatility in the Animal Healthcare Division due to timing of government immunization programs and cited geopolitical challenges in Africa operations as key uncertainties.ScanXHester Biosciences seeks shareholder approval to reclassify promoter groupHester Biosciences is conducting a postal ballot to reclassify Ravin Gandhi and Bela Gandhi from promoter to public shareholders, with results due by September 4, 2026. The move is to ensure compliance with public shareholding norms and involves a vote on the reclassification process. The company also reported a significant profit surge in Q1FY27, driven by debt restructuring and market penetration.Business StandardHester Biosciences consolidated net profit rises 489.90% in the June 2026 quarterHester Biosciences reported a 489.90% rise in consolidated net profit to Rs 96.98 crore for the quarter ended June 2026, compared to Rs 16.44 crore in the same quarter of the previous year. However, the company's sales declined 8.17% to Rs 77.24 crore from Rs 84.11 crore in the corresponding period, while operating profit margin improved to 29.49% from 27.12%.CNBCTV18Q1 Results LIVE Updates: Hester Bio revenue down 8%; Gillette profit up 9%; Swiggy reports todayThe article reports on the Q1 financial results of multiple companies including Hester Bio, Gillette, Swiggy, Bajaj Finance, Mahindra & Mahindra, Tata Steel, Hyundai Motor India, Vedanta, and others. It details revenue declines and profit increases, as well as market reactions to earnings reports.ScanXHester Biosciences Q1 Results: Earnings Call Scheduled for July 30Hester Biosciences Limited has scheduled its Q1FY27 earnings call for July 30, 2026, at 2:00 p.m. IST, to be led by CEO Rajiv Gandhi and CFO Ashish Desai. The announcement complies with SEBI Regulation 30, which mandates disclosure of material events. The page also references a separate July 25 filing regarding the reclassification of Ravin and Bela Gandhi from the Promoter Group to the Public category, approved by NSE and BSE.ScanXHester Biosciences approves financial statements at 39th AGMHester Biosciences Limited held its 39th Annual General Meeting on July 21, 2026, approving audited financial statements for the fiscal year ended March 31, 2026, along with other resolutions including dividend declaration and director re-appointments. The meeting also ratified the remuneration of Cost Auditors. This routine corporate governance event confirms the company's standard annual compliance procedures.YahooHester Biosciences Ltd (BOM:524669) Q3 2026 Earnings Call Highlights: Strong Poultry Growth and ...Hester Biosciences Ltd reported a 12% revenue growth in Q3 of 2026, driven by strong poultry healthcare performance and new regulatory approvals for its avian influenza vaccine. The company expanded capacity with a new fill-finish facility and plans to diversify market focus.BioSpectrum IndiaThe livestock scientistHester Biosciences, led by Dr. JK Pal, is advancing its veterinary vaccine R&D portfolio with multiple products in various stages of development and testing. Key initiatives include a thermostable Newcastle disease vaccine that has completed lab trials, alongside efforts to perfect goat pox and rinderpest vaccines while developing diagnostic kits.The Times of Indiahester biosciences: Veterinary vaccine firms form association for collaboration with policymakers - The Economic TimesIndia's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have formed the Veterinary Vaccine India Manufacturers Association (VVIMA) to serve as the industry's collective voice. The association aims to collaborate with policymakers to foster innovation and position India as a global hub for animal vaccine research and production. Rajiv Gandhi of Hester Biosciences was appointed President of the new body.